Company Profile

Diagnostic Consulting Network Inc (AKA: DCN)
Profile last edited on: 1/29/2016      CAGE: 51TS7      UEI: HDHMAZK2SZV4

Business Identifier: Point of care assay systems
Year Founded
2002
First Award
2011
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6354 Corte Del Abeto Suite B
Carlsbad, CA 92011
   (760) 804-3886
   info@dcndx.com
   www.dcndx.com
Location: Single
Congr. District: 49
County: San Diego

Public Profile

Diagnostic Consulting Network, Inc. develops point of care assay systems. It assists clients in developing, manufacturing, and commercializing point of care lateral flow, flow through, microfluidic, and ELISA assays. Its primary services include contract assay development; design and integration of cassettes, sample handling devices, and strip readers; optimization and production of latex, colloidal gold, and protein conjugates; education and training in lateral flow and flow through assay technology; consulting services; contract manufacturing; and sale of supporting products, including digital readers, assay materials, and critical reagents. The company offers reagents/materials, homogenizers, readers, and Colloidal Gold products. It offers its products for applications, such as medical diagnostics, veterinary diagnostics, consumer diagnostics, biowarfare/biodefense, food and beverage testing, agriculture, forensics, and nucleic acid lateral flow. The company offers its products and services for assay developers and manufacturers. Diagnostic Consulting Network, Inc. is based in Carlsbad, California.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $4,239,251
Project Title: Development of a Field-Deployable Device to Rapidly Measure Blood Cyanide Levels

Key People / Management

  Brendan O'Farrell -- President and Founding Partner

  Hans Boehringer -- Vice President of Technology Development.

  Michael L Surmanian -- Executive Vice President and Founding Partner